Get started
Author

Chin‐Hsien Tsai

Lactate modulation of immune responses in inflammatory versus tumour microenvironments
2020 · Michelangelo Certo, Chin-Hsien Tsai, et al. · Nature reviews. Immunology · 921
Metabolic communication in the tumour–immune microenvironment
2022 · Kung-Chi Kao, Stefania Vilbois, et al. · Nature Cell Biology · 350
Immunoediting instructs tumor metabolic reprogramming to support immune evasion
2023 · Chin-Hsien Tsai, Yu-Ming Chuang, et al. · Cell Metabolism · 113
O ‐Glycosylation‐mediated signaling circuit drives metastatic castration‐resistant prostate cancer
2018 · Sheue‐Fen Tzeng, Chin‐Hsien Tsai, et al. · The FASEB Journal · 63
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al. · Cancer Discovery · 47
PDF
Immunosurveillance encounters cancer metabolism
2024 · Yu-Ming Chuang, Sheue-Fen Tzeng, et al. · EMBO Reports · 31
Fifty Shades of α-Ketoglutarate on Cellular Programming
2019 · Giusy Di Conza, Chin-Hsien Tsai, et al. · Molecular Cell · 29
PDF
Analyses of Mitochondrial Calcium Influx in Isolated Mitochondria and Cultured Cells
2018 · Joshua T. Maxwell, Chin-Hsien Tsai, et al. · Journal of Visualized Experiments · 20
PDF
A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells
2023 · Yao-Wen Chang, Huey-Wen Hsiao, et al. · Cell Reports Medicine · 19
PDF
Analyses of Mitochondrial Calcium Influx in Isolated Mitochondria and Cultured Cells
2018 · Joshua T. Maxwell, Chin-Hsien Tsai, et al. · Journal of Visualized Experiments · 11
1205 PLT012, a humanized CD36-blocking antibody, induces durable anti-tumor immunity via immunometabolic reprogramming
2025 · Yi-Ru Yu, Sheue-Fen Tzeng, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Abstract 2370: Revitalizing anti-tumor immunity through PLT012 monoclonal antibody, targeting CD36 for metabolic rewiring in the tumor microenvironment
2024 · Yi-Ru Yu, Sheue-Fen Tzeng, et al. · Cancer Research · 1
1401 PLT012, a monoclonal antibody targeting CD36, unleashes anti-tumor immunity via metabolic reprogramming in tumor microenvironment
2023 · Yi-Ru Yu, Chin-Hsien Tsai, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Abstract LB-358: Abnormal O-glycosylation promotes prostate cancer stemness and mediates metastatic niche
2018 · Chin-Hsien Tsai, Sheue-Fen Tzeng · Cancer Research · 1
Data from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
Figure S4 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
PDF
Figure S6 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
PDF
Table S1 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
Table S2 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
Figure S1 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
PDF
Figure S2 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
PDF
Figure S5 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
PDF
Table S3 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
Figure S7 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
Figure S3 from PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
2025 · Sheue-Fen Tzeng, Yi-Ru Yu, et al.
PDF
Works count: 31
Citation count: 1,605
H-index: 10
I10-index: 10
Year
Topic
Type